An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Orthofix Medical to Present at Canaccord Genuity 2023 Musculoskeletal Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Orthofix Medical (NASDAQ:OFIX) will present at the Canaccord Genuity 2023 Musculoskeletal Conference in Las Vegas on March 7, 2023, at 2:00 p.m. PT. Interested parties can access the webcast on the Orthofix Investor Relations website.
This follows the company’s merger with SeaSpine on January 5, 2023, creating a leading global spine and orthopedics entity with a broad product portfolio operating in approximately 68 countries. The new name for the combined entity will be announced later, but it will continue to operate as Orthofix until then.
Positive
None.
Negative
None.
LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will present at the upcoming Canaccord Genuity 2023 Musculoskeletal Conference in Las Vegas, NV. Management is scheduled to present on Tuesday, March 7, 2023, at 2:00 p.m. PT.
Interested parties can access a live or archived webcast of the presentation on the Investors section of the Orthofix website at ir.Orthofix.com.
About the Combined Company:
On January 5, 2023, Orthofix and SeaSpine merged to form a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide. The company plans to announce a new name for the combined entity in the future but will continue to operate under the Orthofix name until then.
The Company is headquartered in Lewisville, Texas and has primary offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany, Paris, France and Sao Paulo, Brazil.
